BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 30129221)

  • 1. Silencing CTGF/CCN2 inactivates the MAPK signaling pathway to alleviate myocardial fibrosis and left ventricular hypertrophy in rats with dilated cardiomyopathy.
    Hong L; Lai HL; Fang Y; Tao Y; Qiu Y
    J Cell Biochem; 2018 Nov; 119(11):9519-9531. PubMed ID: 30129221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Connective tissue growth factor regulates cardiac function and tissue remodeling in a mouse model of dilated cardiomyopathy.
    Koshman YE; Sternlicht MD; Kim T; O'Hara CP; Koczor CA; Lewis W; Seeley TW; Lipson KE; Samarel AM
    J Mol Cell Cardiol; 2015 Dec; 89(Pt B):214-22. PubMed ID: 26549358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ERK1/2 directly acts on CTGF/CCN2 expression to mediate myocardial fibrosis in cardiomyopathy caused by mutations in the lamin A/C gene.
    Chatzifrangkeskou M; Le Dour C; Wu W; Morrow JP; Joseph LC; Beuvin M; Sera F; Homma S; Vignier N; Mougenot N; Bonne G; Lipson KE; Worman HJ; Muchir A
    Hum Mol Genet; 2016 Jun; 25(11):2220-2233. PubMed ID: 27131347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taurocholate Induces Connective Tissue Growth Factor Expression in Hepatocytes Through ERK-YAP Signaling.
    Yu B; Jin GN; Ma M; Liang HF; Zhang BX; Chen XP; Ding ZY
    Cell Physiol Biochem; 2018; 50(5):1711-1725. PubMed ID: 30384360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human umbilical cord mesenchymal stem cells alleviate interstitial fibrosis and cardiac dysfunction in a dilated cardiomyopathy rat model by inhibiting TNF‑α and TGF‑β1/ERK1/2 signaling pathways.
    Zhang C; Zhou G; Chen Y; Liu S; Chen F; Xie L; Wang W; Zhang Y; Wang T; Lai X; Ma L
    Mol Med Rep; 2018 Jan; 17(1):71-78. PubMed ID: 29115435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Locally expressed IGF1 propeptide improves mouse heart function in induced dilated cardiomyopathy by blocking myocardial fibrosis and SRF-dependent CTGF induction.
    Touvron M; Escoubet B; Mericskay M; Angelini A; Lamotte L; Santini MP; Rosenthal N; Daegelen D; Tuil D; Decaux JF
    Dis Model Mech; 2012 Jul; 5(4):481-91. PubMed ID: 22563064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olmesartan medoxomil treatment potently improves cardiac myosin-induced dilated cardiomyopathy via the modulation of ACE-2 and ANG 1-7 mas receptor.
    Sukumaran V; Veeraveedu PT; Lakshmanan AP; Gurusamy N; Yamaguchi K; Ma M; Suzuki K; Kodama M; Watanabe K
    Free Radic Res; 2012 Jul; 46(7):850-60. PubMed ID: 22497476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCN2/CTGF attenuates myocardial hypertrophy and cardiac dysfunction upon chronic pressure-overload.
    Gravning J; Ahmed MS; von Lueder TG; Edvardsen T; Attramadal H
    Int J Cardiol; 2013 Oct; 168(3):2049-56. PubMed ID: 23452880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased connective tissue growth factor relative to brain natriuretic peptide as a determinant of myocardial fibrosis.
    Koitabashi N; Arai M; Kogure S; Niwano K; Watanabe A; Aoki Y; Maeno T; Nishida T; Kubota S; Takigawa M; Kurabayashi M
    Hypertension; 2007 May; 49(5):1120-7. PubMed ID: 17372041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-target RNA interference for the blockade of multiple interacting proinflammatory and profibrotic pathways in cardiac fibroblasts.
    Tank J; Lindner D; Wang X; Stroux A; Gilke L; Gast M; Zietsch C; Skurk C; Scheibenbogen C; Klingel K; Lassner D; Kühl U; Schultheiss HP; Westermann D; Poller W
    J Mol Cell Cardiol; 2014 Jan; 66():141-56. PubMed ID: 24239602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling.
    Duisters RF; Tijsen AJ; Schroen B; Leenders JJ; Lentink V; van der Made I; Herias V; van Leeuwen RE; Schellings MW; Barenbrug P; Maessen JG; Heymans S; Pinto YM; Creemers EE
    Circ Res; 2009 Jan; 104(2):170-8, 6p following 178. PubMed ID: 19096030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTGF/CCN2 exerts profibrotic action in myoblasts via the up-regulation of sphingosine kinase-1/S1P3 signaling axis: Implications in the action mechanism of TGFβ.
    Bruno G; Cencetti F; Pertici I; Japtok L; Bernacchioni C; Donati C; Bruni P
    Biochim Biophys Acta; 2015 Feb; 1851(2):194-202. PubMed ID: 25457224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yin Yang 1 Suppresses Dilated Cardiomyopathy and Cardiac Fibrosis Through Regulation of
    Tan CY; Wong JX; Chan PS; Tan H; Liao D; Chen W; Tan LW; Ackers-Johnson M; Wakimoto H; Seidman JG; Seidman CE; Lunde IG; Zhu F; Hu Q; Bian J; Wang JW; Foo RS; Jiang J
    Circ Res; 2019 Oct; 125(9):834-846. PubMed ID: 31495264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LTBP2 knockdown by siRNA reverses myocardial oxidative stress injury, fibrosis and remodelling during dilated cardiomyopathy.
    Pang XF; Lin X; Du JJ; Zeng DY
    Acta Physiol (Oxf); 2020 Mar; 228(3):e13377. PubMed ID: 31512380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse effects of high glucose and free fatty acid on cardiomyocytes are mediated by connective tissue growth factor.
    Wang X; McLennan SV; Allen TJ; Tsoutsman T; Semsarian C; Twigg SM
    Am J Physiol Cell Physiol; 2009 Dec; 297(6):C1490-500. PubMed ID: 19625611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential patterns of replacement and reactive fibrosis in pressure and volume overload are related to the propensity for ischaemia and involve resistin.
    Chemaly ER; Kang S; Zhang S; McCollum L; Chen J; Bénard L; Purushothaman KR; Hajjar RJ; Lebeche D
    J Physiol; 2013 Nov; 591(21):5337-55. PubMed ID: 24018949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mulberry leaf diet protects against progression of experimental autoimmune myocarditis to dilated cardiomyopathy via modulation of oxidative stress and MAPK-mediated apoptosis.
    Arumugam S; Mito S; Thandavarayan RA; Giridharan VV; Pitchaimani V; Karuppagounder V; Harima M; Nomoto M; Suzuki K; Watanabe K
    Cardiovasc Ther; 2013 Dec; 31(6):352-62. PubMed ID: 23480557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor-gamma activation attenuates cardiac fibrosis in type 2 diabetic rats: the effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and of connective tissue growth factor.
    Ihm SH; Chang K; Kim HY; Baek SH; Youn HJ; Seung KB; Kim JH
    Basic Res Cardiol; 2010 May; 105(3):399-407. PubMed ID: 19902320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrosis of extracellular matrix is related to the duration of the disease but is unrelated to the dynamics of collagen metabolism in dilated cardiomyopathy.
    Rubiś P; Wiśniowska-Śmialek S; Wypasek E; Biernacka-Fijalkowska B; Rudnicka-Sosin L; Dziewiecka E; Faltyn P; Khachatryan L; Karabinowska A; Kozanecki A; Tomkiewicz-Pająk L; Podolec P
    Inflamm Res; 2016 Dec; 65(12):941-949. PubMed ID: 27516211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cucurbitacin I Attenuates Cardiomyocyte Hypertrophy via Inhibition of Connective Tissue Growth Factor (CCN2) and TGF- β/Smads Signalings.
    Jeong MH; Kim SJ; Kang H; Park KW; Park WJ; Yang SY; Yang DK
    PLoS One; 2015; 10(8):e0136236. PubMed ID: 26296085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.